Managers

Akero Therapeutics locks in $70 mln Series B

Cambridge, Massachusetts-based Akero Therapeutics Inc, a biotechnology company focused on treating non-alcoholic steatohepatitis and other serious metabolic diseases, has raised $70 million in Series B funding. Janus Henderson Investors led the round with participation from Redmile Group, Boxer Capital of Tavistock Group, Cormorant Asset Management, BVF Partners, Rock Springs Capital, LifeSci Venture Partners, Apple Tree Partners, Atlas Venture, venBio Partners and Versant Ventures.

Fund Performance: A review of San Francisco's venture portfolio from 2015

BCF Ventures grows pool to $12 mln, backs six tech startups

BCF Ventures, a Montréal-based pre-seed and seed-stage venture capital firm, has increased the potential size of its fund to $12 million. Initially capitalized at $5 million by BCF Business Law partners, the fund raised additional commitments from family offices and accredited investors. Led by CEO and Partner Sergio Escobar, BCF and its co-investors provide financing to cloud and software-as-a-service companies leveraging artificial intelligence, big data, analytics and security, primarily in North America. To date, BCF has invested in six companies, including Canada's Bridgr, CareTeam and FleetOps.

Spring Discovery rallies $18 mln Series A

Palo Alto, California-based Spring Discovery, a startup accelerating the discovery of therapies for aging, has raised $18 million in Series A funding, according to a post. First Round and General Catalyst led the round.

Frist Cressey Ventures collects almost $50 mln for second fund

Frist Cressey Ventures has raised almost $50 million for its second fund, according to an SEC filing. The target is $80 million. Based in Nashville, the firm invests in healthcare.

DBL Partners TIAB 2018 targets $125 mln

DBL Partners TIAB 2018 is seeking to raise $125 million, according to an SEC filing. Based in San Francisco, DBL Partners invests in companies that "enable social, environmental and economic benefits," according to its website.

Mediktor fetches $3.4 mln Series A

Brooklyn, New York-based Mediktor, a symptom checker for pre-diagnosis, triage and decision-making support, has raised $3.4 million in Series A funding. Alta Life Sciences Spain I FCR was the lead investor.

Drug developer EpiVario locks in $445K seed

Philadelphia-based EpiVario, an early-stage drug discovery and developer, has raised $445,000 in seed funding. The investors were not named.

GenEdit pulls in $8.5 mln

Berkeley, California-based GenEdit Inc, a developer of next generation therapeutics for genetic diseases, has closed $8.5 million in funding. Data Collective Bio and SK Holdings led the round with participation from other investors that included Sequoia Capital and Bow Capital.

HubSpot launches $30 mln fund

Cambridge, Massachusetts-based HubSpot, a software company, has launched HubSpot Ventures, a $30 million fund, according to a company announcement. HubSpot Ventures is targeting companies "that take the long-view on success by putting their customers first, investing in an inclusive company culture, and delivering highly differentiated products."